AASTROM IS A regenerative medicine company developing autologous cell products for the repair or regeneration of multiple human tissues, based on its proprietary tissue repair cell (TRC) technology. Aastrom is a private biotechnology company based out of Ann Arbor, Michigan, with a board of directors composed of individuals with broad experience at both large public and private biotech and pharmaceutical companies.

Aastrom's TRCs are a proprietary mixture of bone marrow—derived adult stem and progenitor cells produced using patented single—pass perfusion technology in the Aastrom Replicell system. The clinical procedure begins with the collection of a small sample of bone marrow from the patient's hip in an outpatient setting. TRCs are then produced in the automated Replicell system over a 12—day period. It has been demonstrated in ...